Christopher Martin - 19 Nov 2025 Form 3 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Director
Signature
/s/ John R. Moore, Attorney-in-Fact for Christopher Nathan Martin
Issuer symbol
EWTX
Transactions as of
19 Nov 2025
Transactions value $
$0
Form type
3
Filing time
24 Nov 2025, 19:06:19 UTC
Next filing
11 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Martin Christopher Nathan Director 1715 38TH STREET, BOULDER /s/ John R. Moore, Attorney-in-Fact for Christopher Nathan Martin 24 Nov 2025 0002097992

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney